Literature DB >> 2555958

The expression of intermediate filaments in canine mammary glands and their tumors.

E Hellmén1, A Lindgren.   

Abstract

Monoclonal antibodies specific for different types of intermediate filaments (cytokeratin, vimentin, desmin and neurofilaments) were used to study the histogenesis of canine mammary glands and 57 canine mammary tumors by immunocytochemistry. The intra- and interlobular duct epithelium, acinar, and intralobular myoepithelial cells stained positively for cytokeratin. Peripheral ductal and acinar cells, as well as interstitial cells, stained positively for vimentin. A similar staining pattern was seen in adenomas, complex adenomas, benign mixed tumors, ductular carcinomas, and one myoepithelioma-like tumor. Additionally, cytokeratin positive cells were scattered interstitially in one single adenoma, most complex adenomas, some benign mixed tumors, complex carcinomas, and in the malignant mixed tumors. All stromal cells stained positively for vimentin. The fibrosarcomas were positive only for vimentin, while the following expressed both desmin and cytokeratin: epithelial-like cells in one adenoma, three complex adenomas, the myoepithelioma-like tumor, the single comedo carcinoma, two complex carcinomas, the single lobular carcinoma, one malignant mixed tumor, and three osteosarcomas. Epithelial-like cells in one adenoma, six complex adenomas, two benign mixed tumors, two complex carcinomas, the lobular carcinoma, and the malignant schwannoma stained for neurofilaments. Three tumors, one adenoma, one complex adenoma, and the lobular carcinoma expressed both desmin and neurofilaments in addition to cytokeratin and vimentin. The results show the expression of different types of intermediate filaments and indicate that there might be a stem cell origin in most of the canine mammary tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2555958     DOI: 10.1177/030098588902600507

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  5 in total

1.  Characterization of four in vitro established canine mammary carcinoma and one atypical benign mixed tumor cell lines.

Authors:  E Hellmén
Journal:  In Vitro Cell Dev Biol       Date:  1992-05

2.  Growth hormone mRNA in mammary gland tumors of dogs and cats.

Authors:  J A Mol; E van Garderen; P J Selman; J Wolfswinkel; A Rijinberk; G R Rutteman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

3.  Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.

Authors:  Yen-Ling Hsiao; Tai-Zu Hsieh; Chian-Jiun Liou; Yeong-Hsiang Cheng; Chung-Tien Lin; Chi-Yao Chang; Yu-Shen Lai
Journal:  BMC Vet Res       Date:  2014-09-30       Impact factor: 2.741

4.  Retrospective study and immunohistochemical analysis of canine mammary sarcomas.

Authors:  Izabella Dolka; Rafał Sapierzyński; Magdalena Król
Journal:  BMC Vet Res       Date:  2013-12-09       Impact factor: 2.741

5.  The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors.

Authors:  Kota Yoshida; Saori Yoshida; Nan Choisunirachon; Tomochika Saito; Kaori Matsumoto; Kohei Saeki; Manabu Mochizuki; Ryohei Nishimura; Nobuo Sasaki; Takayuki Nakagawa
Journal:  J Vet Med Sci       Date:  2014-06-16       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.